{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 219,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "from docx.api import Document\n",
    "\n",
    "document1 = Document('MKHS190071431-1A肺癌45基因_28靶向3235 (1).docx')\n",
    "table = document1.tables[11]\n",
    "\n",
    "data = []\n",
    "\n",
    "keys = None\n",
    "for i, row in enumerate(table.rows):\n",
    "    text = (cell.text for cell in row.cells)\n",
    "\n",
    "    if i == 0:\n",
    "        keys = tuple(text)\n",
    "        continue\n",
    "    row_data = dict(zip(keys, text))\n",
    "    data.append(row_data)\n",
    "    #print (data)\n",
    "\n",
    "df = pd.DataFrame(data)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 220,
   "metadata": {},
   "outputs": [],
   "source": [
    "list_df = []\n",
    "for i in range(11,21):\n",
    "    table = document1.tables[i]\n",
    "    \n",
    "    data = []\n",
    "    keys = None\n",
    "    for k, row in enumerate(table.rows):\n",
    "        text = (cell.text for cell in row.cells)\n",
    "        if k == 0:\n",
    "            keys = tuple(text)\n",
    "            continue\n",
    "        row_data = dict(zip(keys, text))\n",
    "        data.append(row_data)\n",
    "    df = pd.DataFrame(data)\n",
    "    list_df.append(df)\n",
    "    res = pd.concat(list_df, axis=0, ignore_index=True, sort=True)\n",
    "            "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 221,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>化疗药物</th>\n",
       "      <th>检测位点</th>\n",
       "      <th>检测基因</th>\n",
       "      <th>检测结果</th>\n",
       "      <th>毒副作用风险用药提示(仅供参考)</th>\n",
       "      <th>用药剂量提示(仅供参考)</th>\n",
       "      <th>等级</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>氟尿嘧啶+亚叶酸+伊立替康</td>\n",
       "      <td>rs67376798</td>\n",
       "      <td>DPYD</td>\n",
       "      <td>TT</td>\n",
       "      <td>携带TT基因型的结直肠癌患者，相比于AT基 因型,可能有（1）较高的药物清除，（2）较 低的...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1A</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>氟尿嘧啶+亚叶酸+伊立替康</td>\n",
       "      <td>rs3918290</td>\n",
       "      <td>DPYD</td>\n",
       "      <td>CC</td>\n",
       "      <td>携带CC基因型的结直肠癌患者，相比于CT和 TT基因型，可能有较低的药物毒副风险。 [ PM...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1A</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>氟尿嘧啶+亚叶酸+伊立替康</td>\n",
       "      <td>rs55886062</td>\n",
       "      <td>DPYD</td>\n",
       "      <td>AA</td>\n",
       "      <td>携带AA基因型的结直肠癌患者，相比于AC和 CC基因型，可能有较低的药物毒副风险。 [ PM...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1A</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>氟尿嘧啶+亚叶酸+伊立替康</td>\n",
       "      <td>rs8175347</td>\n",
       "      <td>UGT1A1</td>\n",
       "      <td>(TA)6/(TA)6</td>\n",
       "      <td>携带(TA)6/(TA)6基因型的结直肠癌 患者，相比于(TA)7/(TA)7基因型， 嗜中...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2A</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>氟尿嘧啶+亚叶酸+奥沙利铂</td>\n",
       "      <td>rs67376798</td>\n",
       "      <td>DPYD</td>\n",
       "      <td>TT</td>\n",
       "      <td>携带TT基因型的结直肠癌患者，相比AT基因 型,可能有（1）较高的药物清除，（2）较低 的药...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1A</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>氟尿嘧啶+亚叶酸+奥沙利铂</td>\n",
       "      <td>rs3918290</td>\n",
       "      <td>DPYD</td>\n",
       "      <td>CC</td>\n",
       "      <td>携带CC基因型的结直肠癌患者，相比CT和T T基因型，可能有较低的药物毒副风险。 [P MI...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1A</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>氟尿嘧啶+亚叶酸+奥沙利铂</td>\n",
       "      <td>rs55886062</td>\n",
       "      <td>DPYD</td>\n",
       "      <td>AA</td>\n",
       "      <td>携带AA基因型的结直肠癌患者，相比AC和C C基因型，可能有较低的药物毒副风险。 [P MI...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1A</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>氟尿嘧啶+亚叶酸+奥沙利铂</td>\n",
       "      <td>rs17376848</td>\n",
       "      <td>DPYD</td>\n",
       "      <td>AG</td>\n",
       "      <td>携带AG基因型的结直肠癌患者，相比于GG基 因型，药物毒副风险增加。 [PMID:20 81...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>氟尿嘧啶+亚叶酸+奥沙利铂</td>\n",
       "      <td>rs1801131</td>\n",
       "      <td>MTHFR</td>\n",
       "      <td>TT</td>\n",
       "      <td>携带TT基因型的结直肠癌患者，相比于GG基 因型，可能有较低的药物毒副风险。 [PMI D:...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>氟尿嘧啶+亚叶酸+奥沙利铂</td>\n",
       "      <td>rs1801133</td>\n",
       "      <td>MTHFR</td>\n",
       "      <td>AA</td>\n",
       "      <td>携带AA基因型的结直肠癌患者，相比于AG和 GG基因型，药物毒副反应风险可能增加。 [ PM...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>氟尿嘧啶+亚叶酸+奥沙利铂</td>\n",
       "      <td>rs11615</td>\n",
       "      <td>ERCC1</td>\n",
       "      <td>AG</td>\n",
       "      <td>携带AG基因型的结直肠癌患者，相比于AA基 因型，嗜中性白血球减少症风险可能减小。 [ PM...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>氟尿嘧啶+亚叶酸</td>\n",
       "      <td>rs67376798</td>\n",
       "      <td>DPYD</td>\n",
       "      <td>TT</td>\n",
       "      <td>携带TT基因型的结直肠癌患者，相比于AT基 因型,可能有（1）较高的药物清除，（2）较 低的...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1A</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>氟尿嘧啶+亚叶酸</td>\n",
       "      <td>rs3918290</td>\n",
       "      <td>DPYD</td>\n",
       "      <td>CC</td>\n",
       "      <td>携带CC基因型的结直肠癌患者，相比CT和T T基因型，可能有较低的药物毒副风险。 [P MI...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1A</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>氟尿嘧啶+亚叶酸</td>\n",
       "      <td>rs55886062</td>\n",
       "      <td>DPYD</td>\n",
       "      <td>AA</td>\n",
       "      <td>携带AA基因型的结直肠癌患者，相比AC和C C基因型，可能有较低的药物毒副风险。 [P MI...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1A</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>氟尿嘧啶+亚叶酸</td>\n",
       "      <td>rs17376848</td>\n",
       "      <td>DPYD</td>\n",
       "      <td>AG</td>\n",
       "      <td>携带AG基因型的结直肠癌患者，相比于GG基 因型，药物毒副风险增加。 [PMID:20 81...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>氟尿嘧啶+亚叶酸</td>\n",
       "      <td>rs1801019</td>\n",
       "      <td>UMPS</td>\n",
       "      <td>GG</td>\n",
       "      <td>携带GG基因型的结直肠癌患者，相比于CC基 因型，可能有较低的药物毒副风险（包括腹泻和 3级...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2B</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>氟尿嘧啶+亚叶酸</td>\n",
       "      <td>rs1801131</td>\n",
       "      <td>MTHFR</td>\n",
       "      <td>TT</td>\n",
       "      <td>携带TT基因型的结直肠癌患者，相比于GG基 因型，可能有较低的药物毒副风险。 [PMI D:...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>氟尿嘧啶+亚叶酸</td>\n",
       "      <td>rs1801133</td>\n",
       "      <td>MTHFR</td>\n",
       "      <td>AA</td>\n",
       "      <td>携带AA基因型的结直肠癌患者，相比于GG基 因型患者，药物毒副反应风险可能增加。 [P MI...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>喃氟啶+亚叶酸</td>\n",
       "      <td>rs67376798</td>\n",
       "      <td>DPYD</td>\n",
       "      <td>TT</td>\n",
       "      <td>携带TT型基因的结直肠癌患者，相比AT基因 型,可能有（1）较高的药物清除，（2）较低 的腹...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1A</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>喃氟啶+亚叶酸</td>\n",
       "      <td>rs3918290</td>\n",
       "      <td>DPYD</td>\n",
       "      <td>CC</td>\n",
       "      <td>携带CC基因型的结直肠癌患者，相比于CT和 TT基因型,可能有较低的腹泻风险。 [PM ID...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1A</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>喃氟啶+亚叶酸</td>\n",
       "      <td>rs1801019</td>\n",
       "      <td>UMPS</td>\n",
       "      <td>GG</td>\n",
       "      <td>携带GG基因型的结直肠癌患者，相比于CC基 因型，可能有较低的药物毒副风险（包括腹泻和 3级...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2B</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>卡培他滨+伊立替康</td>\n",
       "      <td>rs67376798</td>\n",
       "      <td>DPYD</td>\n",
       "      <td>TT</td>\n",
       "      <td>携带TT基因型的结直肠癌患者，相比AT基因 型,可能有（1）较高的药物清除，（2）较低 的药...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1A</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>卡培他滨+伊立替康</td>\n",
       "      <td>rs3918290</td>\n",
       "      <td>DPYD</td>\n",
       "      <td>CC</td>\n",
       "      <td>携带CC基因型的结直肠癌患者，相比CT和T T基因型，可能有较低的药物毒副风险。 [P MI...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1A</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>卡培他滨+伊立替康</td>\n",
       "      <td>rs8175347</td>\n",
       "      <td>UGT1A1</td>\n",
       "      <td>(TA)6/(TA)6</td>\n",
       "      <td>携带(TA)6/(TA)6基因型的结直肠癌 患者，相比于(TA)7/(TA)7基因型， 嗜中...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2A</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>卡培他滨+奥沙利铂</td>\n",
       "      <td>rs67376798</td>\n",
       "      <td>DPYD</td>\n",
       "      <td>TT</td>\n",
       "      <td>携带TT基因型的结直肠癌患者，相比AT基因 型,可能有（1）较高的药物清除，（2）较低 的药...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1A</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>卡培他滨+奥沙利铂</td>\n",
       "      <td>rs3918290</td>\n",
       "      <td>DPYD</td>\n",
       "      <td>CC</td>\n",
       "      <td>携带CC基因型的结直肠癌患者，相比CT和T T基因型，可能有较低的药物毒副风险。 [P MI...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1A</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>环磷酰胺+表阿霉素</td>\n",
       "      <td>rs1695</td>\n",
       "      <td>GSTP1</td>\n",
       "      <td>AA</td>\n",
       "      <td>携带AA基因型的乳腺癌患者，相比于GG基因 型，可能有较低的药物毒副风险。 [PMID :2...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2A</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>卡铂+紫杉醇</td>\n",
       "      <td>rs1695</td>\n",
       "      <td>GSTP1</td>\n",
       "      <td>AA</td>\n",
       "      <td>携带AA基因型的卵巢癌患者，相比于AG或G G基因型，可能有较高的血液毒性风险。 [P MI...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2A</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>顺铂+环磷酰胺</td>\n",
       "      <td>rs3212986</td>\n",
       "      <td>ERCC1</td>\n",
       "      <td>AC</td>\n",
       "      <td>携带AC基因型的卵巢癌患者，相比于CC基因 型，可能有较高的肾毒性风险。 [PMID: 19...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2B</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>顺铂+环磷酰胺</td>\n",
       "      <td>rs11615</td>\n",
       "      <td>ERCC1</td>\n",
       "      <td>AG</td>\n",
       "      <td>携带AG基因型的卵巢癌患者，相比于GG基因 型，可能有较高的肾毒性风险；然而也有不一致 性结...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>98</th>\n",
       "      <td>卡铂+紫杉醇</td>\n",
       "      <td>rs11615</td>\n",
       "      <td>ERCC1</td>\n",
       "      <td>AG</td>\n",
       "      <td>携带AA基因型的卵巢癌患者，相比于GG基因 型，可能有较差的药物缓解率，较高的疾病复发 风险...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2B</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>99</th>\n",
       "      <td>顺铂+环磷酰胺</td>\n",
       "      <td>rs11615</td>\n",
       "      <td>ERCC1</td>\n",
       "      <td>AG</td>\n",
       "      <td>携带AA基因型的卵巢癌患者，相比于GG基因 型，可能有较差的药物缓解率，较高的疾病复发 风险...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2B</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>100</th>\n",
       "      <td>顺铂+环磷酰胺</td>\n",
       "      <td>rs25487</td>\n",
       "      <td>XRCC1</td>\n",
       "      <td>CT</td>\n",
       "      <td>携带CT基因型的卵巢癌患者，相比于CC基因 型，可能有较低的生存率及药物缓解率，但也存 在结...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2B</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>101</th>\n",
       "      <td>顺铂+环磷酰胺</td>\n",
       "      <td>rs1695</td>\n",
       "      <td>GSTP1</td>\n",
       "      <td>AA</td>\n",
       "      <td>携带AA基因型的卵巢癌患者，相比于AG和G G基因型，可能有较长的无进展生存期；然而也 有结...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>102</th>\n",
       "      <td>顺铂+环磷酰胺</td>\n",
       "      <td>rs1142345</td>\n",
       "      <td>TPMT</td>\n",
       "      <td>TT</td>\n",
       "      <td>携带TT基因型的卵巢癌患者，相比于CT基因 型，可能会增加无进展生存期。 [PMID: 24...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>103</th>\n",
       "      <td>顺铂+紫杉醇</td>\n",
       "      <td>rs11615</td>\n",
       "      <td>ERCC1</td>\n",
       "      <td>AG</td>\n",
       "      <td>携带AA基因型的卵巢癌患者，相比于GG基因 型，可能有较差的药物缓解率，较高的疾病复发 风险...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2B</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>104</th>\n",
       "      <td>顺铂+氟尿嘧啶</td>\n",
       "      <td>rs3212986</td>\n",
       "      <td>ERCC1</td>\n",
       "      <td>AC</td>\n",
       "      <td>携带AC基因型的食管癌患者，相比于CC基因 型，可能有较好的总体生存率。 [PMID: 23...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>105</th>\n",
       "      <td>顺铂+紫杉醇</td>\n",
       "      <td>rs1042522</td>\n",
       "      <td>TP53</td>\n",
       "      <td>CC</td>\n",
       "      <td>携带CC基因型的胃癌患者，相比于CG和GG 基因型，可能有较好的药物缓解率和较长的一年 无进...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2B</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>106</th>\n",
       "      <td>顺铂+多西他赛+吉西他滨+卡培他滨</td>\n",
       "      <td>rs11615</td>\n",
       "      <td>ERCC1</td>\n",
       "      <td>AG</td>\n",
       "      <td>携带AG基因型的胰腺癌患者，相比于AA基因 型，可能有较短的总体生存期。该基因型与无进 展生...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2B</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>107</th>\n",
       "      <td>顺铂+多西他赛+吉西他滨+卡培他滨</td>\n",
       "      <td>rs25487</td>\n",
       "      <td>XRCC1</td>\n",
       "      <td>CT</td>\n",
       "      <td>携带CT基因型的胰腺癌患者，相比于CC基因 型，可能有较短的总体生存期。该基因型与无进 展生...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2B</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>108</th>\n",
       "      <td>顺铂+表阿霉素+吉西他滨+卡培他滨</td>\n",
       "      <td>rs11615</td>\n",
       "      <td>ERCC1</td>\n",
       "      <td>AG</td>\n",
       "      <td>携带AG基因型的胰腺癌患者，相比于AA基因 型，可能有较短的总体生存期。该基因型与无进 展生...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2B</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>109</th>\n",
       "      <td>顺铂+表阿霉素+吉西他滨+卡培他滨</td>\n",
       "      <td>rs25487</td>\n",
       "      <td>XRCC1</td>\n",
       "      <td>CT</td>\n",
       "      <td>携带CT基因型的胰腺癌患者，相比于CC基因 型，可能有较短的总体生存期。该基因型与无进 展生...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2B</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>110</th>\n",
       "      <td>培美曲塞</td>\n",
       "      <td>rs1801133</td>\n",
       "      <td>MTHFR</td>\n",
       "      <td>AA</td>\n",
       "      <td>携带AA基因型的非小细胞肺癌或者间皮瘤患者 ，相比于GG基因型，可能有较短的总生存期。  [...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>111</th>\n",
       "      <td>环磷酰胺</td>\n",
       "      <td>rs4880</td>\n",
       "      <td>SOD2</td>\n",
       "      <td>AA</td>\n",
       "      <td>携带AA基因型的乳腺癌患者，相比于GG基因 型，可能会有较高的生存期。 [PMID:1 95...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2B</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>112</th>\n",
       "      <td>环磷酰胺</td>\n",
       "      <td>rs25487</td>\n",
       "      <td>XRCC1</td>\n",
       "      <td>CT</td>\n",
       "      <td>携带CT基因型的卵巢癌患者，相比于CC基因 型，可能有较低的生存期。 [PMID:22 18...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>113</th>\n",
       "      <td>西妥昔单抗</td>\n",
       "      <td>rs396991</td>\n",
       "      <td>FCGR3A</td>\n",
       "      <td>AC</td>\n",
       "      <td>携带AC基因型的肿瘤患者，相比于CC基因型 ，可能有较好的药物缓解率和较好的治疗效果。  [...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2B</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>114</th>\n",
       "      <td>他莫昔芬</td>\n",
       "      <td>rs3892097</td>\n",
       "      <td>CYP2D6</td>\n",
       "      <td>CC</td>\n",
       "      <td>携带CC基因型的乳腺癌患者，相比于TT基因 型，可能有较长的无进展生存期和无事件生存期 和较...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2A</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>115</th>\n",
       "      <td>紫杉醇</td>\n",
       "      <td>rs1042522</td>\n",
       "      <td>TP53</td>\n",
       "      <td>CC</td>\n",
       "      <td>携带CC基因型的胃癌患者，相比于CG和GG 基因型，可能有较好的药物缓解率和较长的一年 无进...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2B</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>116</th>\n",
       "      <td>卡铂</td>\n",
       "      <td>rs1801133</td>\n",
       "      <td>MTHFR</td>\n",
       "      <td>AA</td>\n",
       "      <td>携带AA基因型的非小细胞肺癌或者间皮瘤患者 ，相比于AG和GG基因型，可能有较好的药物 缓解...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2A</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>117</th>\n",
       "      <td>卡铂</td>\n",
       "      <td>rs11615</td>\n",
       "      <td>ERCC1</td>\n",
       "      <td>AG</td>\n",
       "      <td>携带AG基因型的非小细胞肺癌患者，相比于G G基因型有较好药物缓解率；也有结论不一致性 研究...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2B</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>118</th>\n",
       "      <td>卡铂</td>\n",
       "      <td>rs3212986</td>\n",
       "      <td>ERCC1</td>\n",
       "      <td>AC</td>\n",
       "      <td>携带AC基因型的肿瘤患者，相比于CC基因型 ，可能有较高的总体生存率；然而也有结论不一 致性...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>119</th>\n",
       "      <td>卡铂</td>\n",
       "      <td>rs25487</td>\n",
       "      <td>XRCC1</td>\n",
       "      <td>CT</td>\n",
       "      <td>携带CT基因型的非小细胞肺癌患者，相比于C C基因型，可能有较高的药物缓解率和较长的总 生存...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2B</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>120</th>\n",
       "      <td>奥沙利铂</td>\n",
       "      <td>rs11615</td>\n",
       "      <td>ERCC1</td>\n",
       "      <td>AG</td>\n",
       "      <td>携带AG基因型的结直肠癌患者，相比于GG基 因型，总生存期和无进展生存期可能缩短。 [ PM...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2B</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121</th>\n",
       "      <td>奥沙利铂</td>\n",
       "      <td>rs25487</td>\n",
       "      <td>XRCC1</td>\n",
       "      <td>CT</td>\n",
       "      <td>携带CT基因型的结直肠癌患者，相比于CC基 因型，可能有较短的总体生存期和无进展生存期 。 ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2B</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>122</th>\n",
       "      <td>顺铂</td>\n",
       "      <td>rs11615</td>\n",
       "      <td>ERCC1</td>\n",
       "      <td>AG</td>\n",
       "      <td>携带AG基因型的非小细胞肺癌患者，相比于G G基因型有较好药物缓解率；然而也有不一致研 究结...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2B</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>123</th>\n",
       "      <td>顺铂</td>\n",
       "      <td>rs3212986</td>\n",
       "      <td>ERCC1</td>\n",
       "      <td>AC</td>\n",
       "      <td>携带AC基因型的肿瘤患者，相比于CC基因型 ，可能有较高的总体生存率；也有结论不一致性 研究...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>124</th>\n",
       "      <td>顺铂</td>\n",
       "      <td>rs1042522</td>\n",
       "      <td>TP53</td>\n",
       "      <td>CC</td>\n",
       "      <td>携带CC基因型的胃癌患者，相比于CG和GG 基因型，可能有较好的药物缓解率和较长的一年 无进...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2B</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>125</th>\n",
       "      <td>顺铂</td>\n",
       "      <td>rs25487</td>\n",
       "      <td>XRCC1</td>\n",
       "      <td>CT</td>\n",
       "      <td>携带CT基因型的非小细胞肺癌患者，相比于C C基因型，可能有较高的药物缓解率和较长的总 生存...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2B</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>126</th>\n",
       "      <td>顺铂</td>\n",
       "      <td>rs1801133</td>\n",
       "      <td>MTHFR</td>\n",
       "      <td>AA</td>\n",
       "      <td>携带AA基因型的非小细胞肺癌患者，相比于G G基因型，可能有较好的药物缓解率。 [PM ID...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>127</th>\n",
       "      <td>伊立替康</td>\n",
       "      <td>rs8175347</td>\n",
       "      <td>UGT1A1</td>\n",
       "      <td>(TA)6/(TA)6</td>\n",
       "      <td>NaN</td>\n",
       "      <td>携带(TA)6/(TA)6基因型的肿瘤患者 ，使用伊立替康为基础的治疗，正常剂量使用。  [...</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>128 rows × 7 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                  化疗药物        检测位点    检测基因         检测结果  \\\n",
       "0        氟尿嘧啶+亚叶酸+伊立替康  rs67376798    DPYD           TT   \n",
       "1        氟尿嘧啶+亚叶酸+伊立替康   rs3918290    DPYD           CC   \n",
       "2        氟尿嘧啶+亚叶酸+伊立替康  rs55886062    DPYD           AA   \n",
       "3        氟尿嘧啶+亚叶酸+伊立替康   rs8175347  UGT1A1  (TA)6/(TA)6   \n",
       "4        氟尿嘧啶+亚叶酸+奥沙利铂  rs67376798    DPYD           TT   \n",
       "5        氟尿嘧啶+亚叶酸+奥沙利铂   rs3918290    DPYD           CC   \n",
       "6        氟尿嘧啶+亚叶酸+奥沙利铂  rs55886062    DPYD           AA   \n",
       "7        氟尿嘧啶+亚叶酸+奥沙利铂  rs17376848    DPYD           AG   \n",
       "8        氟尿嘧啶+亚叶酸+奥沙利铂   rs1801131   MTHFR           TT   \n",
       "9        氟尿嘧啶+亚叶酸+奥沙利铂   rs1801133   MTHFR           AA   \n",
       "10       氟尿嘧啶+亚叶酸+奥沙利铂     rs11615   ERCC1           AG   \n",
       "11            氟尿嘧啶+亚叶酸  rs67376798    DPYD           TT   \n",
       "12            氟尿嘧啶+亚叶酸   rs3918290    DPYD           CC   \n",
       "13            氟尿嘧啶+亚叶酸  rs55886062    DPYD           AA   \n",
       "14            氟尿嘧啶+亚叶酸  rs17376848    DPYD           AG   \n",
       "15            氟尿嘧啶+亚叶酸   rs1801019    UMPS           GG   \n",
       "16            氟尿嘧啶+亚叶酸   rs1801131   MTHFR           TT   \n",
       "17            氟尿嘧啶+亚叶酸   rs1801133   MTHFR           AA   \n",
       "18             喃氟啶+亚叶酸  rs67376798    DPYD           TT   \n",
       "19             喃氟啶+亚叶酸   rs3918290    DPYD           CC   \n",
       "20             喃氟啶+亚叶酸   rs1801019    UMPS           GG   \n",
       "21           卡培他滨+伊立替康  rs67376798    DPYD           TT   \n",
       "22           卡培他滨+伊立替康   rs3918290    DPYD           CC   \n",
       "23           卡培他滨+伊立替康   rs8175347  UGT1A1  (TA)6/(TA)6   \n",
       "24           卡培他滨+奥沙利铂  rs67376798    DPYD           TT   \n",
       "25           卡培他滨+奥沙利铂   rs3918290    DPYD           CC   \n",
       "26           环磷酰胺+表阿霉素      rs1695   GSTP1           AA   \n",
       "27              卡铂+紫杉醇      rs1695   GSTP1           AA   \n",
       "28             顺铂+环磷酰胺   rs3212986   ERCC1           AC   \n",
       "29             顺铂+环磷酰胺     rs11615   ERCC1           AG   \n",
       "..                 ...         ...     ...          ...   \n",
       "98              卡铂+紫杉醇     rs11615   ERCC1           AG   \n",
       "99             顺铂+环磷酰胺     rs11615   ERCC1           AG   \n",
       "100            顺铂+环磷酰胺     rs25487   XRCC1           CT   \n",
       "101            顺铂+环磷酰胺      rs1695   GSTP1           AA   \n",
       "102            顺铂+环磷酰胺   rs1142345    TPMT           TT   \n",
       "103             顺铂+紫杉醇     rs11615   ERCC1           AG   \n",
       "104            顺铂+氟尿嘧啶   rs3212986   ERCC1           AC   \n",
       "105             顺铂+紫杉醇   rs1042522    TP53           CC   \n",
       "106  顺铂+多西他赛+吉西他滨+卡培他滨     rs11615   ERCC1           AG   \n",
       "107  顺铂+多西他赛+吉西他滨+卡培他滨     rs25487   XRCC1           CT   \n",
       "108  顺铂+表阿霉素+吉西他滨+卡培他滨     rs11615   ERCC1           AG   \n",
       "109  顺铂+表阿霉素+吉西他滨+卡培他滨     rs25487   XRCC1           CT   \n",
       "110               培美曲塞   rs1801133   MTHFR           AA   \n",
       "111               环磷酰胺      rs4880    SOD2           AA   \n",
       "112               环磷酰胺     rs25487   XRCC1           CT   \n",
       "113              西妥昔单抗    rs396991  FCGR3A           AC   \n",
       "114               他莫昔芬   rs3892097  CYP2D6           CC   \n",
       "115                紫杉醇   rs1042522    TP53           CC   \n",
       "116                 卡铂   rs1801133   MTHFR           AA   \n",
       "117                 卡铂     rs11615   ERCC1           AG   \n",
       "118                 卡铂   rs3212986   ERCC1           AC   \n",
       "119                 卡铂     rs25487   XRCC1           CT   \n",
       "120               奥沙利铂     rs11615   ERCC1           AG   \n",
       "121               奥沙利铂     rs25487   XRCC1           CT   \n",
       "122                 顺铂     rs11615   ERCC1           AG   \n",
       "123                 顺铂   rs3212986   ERCC1           AC   \n",
       "124                 顺铂   rs1042522    TP53           CC   \n",
       "125                 顺铂     rs25487   XRCC1           CT   \n",
       "126                 顺铂   rs1801133   MTHFR           AA   \n",
       "127               伊立替康   rs8175347  UGT1A1  (TA)6/(TA)6   \n",
       "\n",
       "                                      毒副作用风险用药提示(仅供参考)  \\\n",
       "0    携带TT基因型的结直肠癌患者，相比于AT基 因型,可能有（1）较高的药物清除，（2）较 低的...   \n",
       "1    携带CC基因型的结直肠癌患者，相比于CT和 TT基因型，可能有较低的药物毒副风险。 [ PM...   \n",
       "2    携带AA基因型的结直肠癌患者，相比于AC和 CC基因型，可能有较低的药物毒副风险。 [ PM...   \n",
       "3    携带(TA)6/(TA)6基因型的结直肠癌 患者，相比于(TA)7/(TA)7基因型， 嗜中...   \n",
       "4    携带TT基因型的结直肠癌患者，相比AT基因 型,可能有（1）较高的药物清除，（2）较低 的药...   \n",
       "5    携带CC基因型的结直肠癌患者，相比CT和T T基因型，可能有较低的药物毒副风险。 [P MI...   \n",
       "6    携带AA基因型的结直肠癌患者，相比AC和C C基因型，可能有较低的药物毒副风险。 [P MI...   \n",
       "7    携带AG基因型的结直肠癌患者，相比于GG基 因型，药物毒副风险增加。 [PMID:20 81...   \n",
       "8    携带TT基因型的结直肠癌患者，相比于GG基 因型，可能有较低的药物毒副风险。 [PMI D:...   \n",
       "9    携带AA基因型的结直肠癌患者，相比于AG和 GG基因型，药物毒副反应风险可能增加。 [ PM...   \n",
       "10   携带AG基因型的结直肠癌患者，相比于AA基 因型，嗜中性白血球减少症风险可能减小。 [ PM...   \n",
       "11   携带TT基因型的结直肠癌患者，相比于AT基 因型,可能有（1）较高的药物清除，（2）较 低的...   \n",
       "12   携带CC基因型的结直肠癌患者，相比CT和T T基因型，可能有较低的药物毒副风险。 [P MI...   \n",
       "13   携带AA基因型的结直肠癌患者，相比AC和C C基因型，可能有较低的药物毒副风险。 [P MI...   \n",
       "14   携带AG基因型的结直肠癌患者，相比于GG基 因型，药物毒副风险增加。 [PMID:20 81...   \n",
       "15   携带GG基因型的结直肠癌患者，相比于CC基 因型，可能有较低的药物毒副风险（包括腹泻和 3级...   \n",
       "16   携带TT基因型的结直肠癌患者，相比于GG基 因型，可能有较低的药物毒副风险。 [PMI D:...   \n",
       "17   携带AA基因型的结直肠癌患者，相比于GG基 因型患者，药物毒副反应风险可能增加。 [P MI...   \n",
       "18   携带TT型基因的结直肠癌患者，相比AT基因 型,可能有（1）较高的药物清除，（2）较低 的腹...   \n",
       "19   携带CC基因型的结直肠癌患者，相比于CT和 TT基因型,可能有较低的腹泻风险。 [PM ID...   \n",
       "20   携带GG基因型的结直肠癌患者，相比于CC基 因型，可能有较低的药物毒副风险（包括腹泻和 3级...   \n",
       "21   携带TT基因型的结直肠癌患者，相比AT基因 型,可能有（1）较高的药物清除，（2）较低 的药...   \n",
       "22   携带CC基因型的结直肠癌患者，相比CT和T T基因型，可能有较低的药物毒副风险。 [P MI...   \n",
       "23   携带(TA)6/(TA)6基因型的结直肠癌 患者，相比于(TA)7/(TA)7基因型， 嗜中...   \n",
       "24   携带TT基因型的结直肠癌患者，相比AT基因 型,可能有（1）较高的药物清除，（2）较低 的药...   \n",
       "25   携带CC基因型的结直肠癌患者，相比CT和T T基因型，可能有较低的药物毒副风险。 [P MI...   \n",
       "26   携带AA基因型的乳腺癌患者，相比于GG基因 型，可能有较低的药物毒副风险。 [PMID :2...   \n",
       "27   携带AA基因型的卵巢癌患者，相比于AG或G G基因型，可能有较高的血液毒性风险。 [P MI...   \n",
       "28   携带AC基因型的卵巢癌患者，相比于CC基因 型，可能有较高的肾毒性风险。 [PMID: 19...   \n",
       "29   携带AG基因型的卵巢癌患者，相比于GG基因 型，可能有较高的肾毒性风险；然而也有不一致 性结...   \n",
       "..                                                 ...   \n",
       "98   携带AA基因型的卵巢癌患者，相比于GG基因 型，可能有较差的药物缓解率，较高的疾病复发 风险...   \n",
       "99   携带AA基因型的卵巢癌患者，相比于GG基因 型，可能有较差的药物缓解率，较高的疾病复发 风险...   \n",
       "100  携带CT基因型的卵巢癌患者，相比于CC基因 型，可能有较低的生存率及药物缓解率，但也存 在结...   \n",
       "101  携带AA基因型的卵巢癌患者，相比于AG和G G基因型，可能有较长的无进展生存期；然而也 有结...   \n",
       "102  携带TT基因型的卵巢癌患者，相比于CT基因 型，可能会增加无进展生存期。 [PMID: 24...   \n",
       "103  携带AA基因型的卵巢癌患者，相比于GG基因 型，可能有较差的药物缓解率，较高的疾病复发 风险...   \n",
       "104  携带AC基因型的食管癌患者，相比于CC基因 型，可能有较好的总体生存率。 [PMID: 23...   \n",
       "105  携带CC基因型的胃癌患者，相比于CG和GG 基因型，可能有较好的药物缓解率和较长的一年 无进...   \n",
       "106  携带AG基因型的胰腺癌患者，相比于AA基因 型，可能有较短的总体生存期。该基因型与无进 展生...   \n",
       "107  携带CT基因型的胰腺癌患者，相比于CC基因 型，可能有较短的总体生存期。该基因型与无进 展生...   \n",
       "108  携带AG基因型的胰腺癌患者，相比于AA基因 型，可能有较短的总体生存期。该基因型与无进 展生...   \n",
       "109  携带CT基因型的胰腺癌患者，相比于CC基因 型，可能有较短的总体生存期。该基因型与无进 展生...   \n",
       "110  携带AA基因型的非小细胞肺癌或者间皮瘤患者 ，相比于GG基因型，可能有较短的总生存期。  [...   \n",
       "111  携带AA基因型的乳腺癌患者，相比于GG基因 型，可能会有较高的生存期。 [PMID:1 95...   \n",
       "112  携带CT基因型的卵巢癌患者，相比于CC基因 型，可能有较低的生存期。 [PMID:22 18...   \n",
       "113  携带AC基因型的肿瘤患者，相比于CC基因型 ，可能有较好的药物缓解率和较好的治疗效果。  [...   \n",
       "114  携带CC基因型的乳腺癌患者，相比于TT基因 型，可能有较长的无进展生存期和无事件生存期 和较...   \n",
       "115  携带CC基因型的胃癌患者，相比于CG和GG 基因型，可能有较好的药物缓解率和较长的一年 无进...   \n",
       "116  携带AA基因型的非小细胞肺癌或者间皮瘤患者 ，相比于AG和GG基因型，可能有较好的药物 缓解...   \n",
       "117  携带AG基因型的非小细胞肺癌患者，相比于G G基因型有较好药物缓解率；也有结论不一致性 研究...   \n",
       "118  携带AC基因型的肿瘤患者，相比于CC基因型 ，可能有较高的总体生存率；然而也有结论不一 致性...   \n",
       "119  携带CT基因型的非小细胞肺癌患者，相比于C C基因型，可能有较高的药物缓解率和较长的总 生存...   \n",
       "120  携带AG基因型的结直肠癌患者，相比于GG基 因型，总生存期和无进展生存期可能缩短。 [ PM...   \n",
       "121  携带CT基因型的结直肠癌患者，相比于CC基 因型，可能有较短的总体生存期和无进展生存期 。 ...   \n",
       "122  携带AG基因型的非小细胞肺癌患者，相比于G G基因型有较好药物缓解率；然而也有不一致研 究结...   \n",
       "123  携带AC基因型的肿瘤患者，相比于CC基因型 ，可能有较高的总体生存率；也有结论不一致性 研究...   \n",
       "124  携带CC基因型的胃癌患者，相比于CG和GG 基因型，可能有较好的药物缓解率和较长的一年 无进...   \n",
       "125  携带CT基因型的非小细胞肺癌患者，相比于C C基因型，可能有较高的药物缓解率和较长的总 生存...   \n",
       "126  携带AA基因型的非小细胞肺癌患者，相比于G G基因型，可能有较好的药物缓解率。 [PM ID...   \n",
       "127                                                NaN   \n",
       "\n",
       "                                          用药剂量提示(仅供参考)  等级  \n",
       "0                                                  NaN  1A  \n",
       "1                                                  NaN  1A  \n",
       "2                                                  NaN  1A  \n",
       "3                                                  NaN  2A  \n",
       "4                                                  NaN  1A  \n",
       "5                                                  NaN  1A  \n",
       "6                                                  NaN  1A  \n",
       "7                                                  NaN   3  \n",
       "8                                                  NaN   3  \n",
       "9                                                  NaN   3  \n",
       "10                                                 NaN   3  \n",
       "11                                                 NaN  1A  \n",
       "12                                                 NaN  1A  \n",
       "13                                                 NaN  1A  \n",
       "14                                                 NaN   3  \n",
       "15                                                 NaN  2B  \n",
       "16                                                 NaN   3  \n",
       "17                                                 NaN   3  \n",
       "18                                                 NaN  1A  \n",
       "19                                                 NaN  1A  \n",
       "20                                                 NaN  2B  \n",
       "21                                                 NaN  1A  \n",
       "22                                                 NaN  1A  \n",
       "23                                                 NaN  2A  \n",
       "24                                                 NaN  1A  \n",
       "25                                                 NaN  1A  \n",
       "26                                                 NaN  2A  \n",
       "27                                                 NaN  2A  \n",
       "28                                                 NaN  2B  \n",
       "29                                                 NaN   3  \n",
       "..                                                 ...  ..  \n",
       "98                                                 NaN  2B  \n",
       "99                                                 NaN  2B  \n",
       "100                                                NaN  2B  \n",
       "101                                                NaN   3  \n",
       "102                                                NaN   3  \n",
       "103                                                NaN  2B  \n",
       "104                                                NaN   3  \n",
       "105                                                NaN  2B  \n",
       "106                                                NaN  2B  \n",
       "107                                                NaN  2B  \n",
       "108                                                NaN  2B  \n",
       "109                                                NaN  2B  \n",
       "110                                                NaN   3  \n",
       "111                                                NaN  2B  \n",
       "112                                                NaN   3  \n",
       "113                                                NaN  2B  \n",
       "114                                                NaN  2A  \n",
       "115                                                NaN  2B  \n",
       "116                                                NaN  2A  \n",
       "117                                                NaN  2B  \n",
       "118                                                NaN   3  \n",
       "119                                                NaN  2B  \n",
       "120                                                NaN  2B  \n",
       "121                                                NaN  2B  \n",
       "122                                                NaN  2B  \n",
       "123                                                NaN   3  \n",
       "124                                                NaN  2B  \n",
       "125                                                NaN  2B  \n",
       "126                                                NaN   3  \n",
       "127  携带(TA)6/(TA)6基因型的肿瘤患者 ，使用伊立替康为基础的治疗，正常剂量使用。  [...   3  \n",
       "\n",
       "[128 rows x 7 columns]"
      ]
     },
     "execution_count": 221,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "res"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 222,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'AA'"
      ]
     },
     "execution_count": 222,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#根据检测位点，选出对应的基因型\n",
    "res.loc[res['检测位点'] == 'rs1695', '检测结果'].iloc[0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 223,
   "metadata": {},
   "outputs": [],
   "source": [
    "document = Document('泛癌种50基因化疗部分模板0919.docx')\n",
    "table = document.tables[0]\n",
    "\n",
    "data = []\n",
    "\n",
    "keys = None\n",
    "for i, row in enumerate(table.rows):\n",
    "    text = (cell.text for cell in row.cells)\n",
    "\n",
    "    if i == 0:\n",
    "        keys = tuple(text)\n",
    "        continue\n",
    "    row_data = dict(zip(keys, text))\n",
    "    data.append(row_data)\n",
    "    #print (data)\n",
    "\n",
    "df = pd.DataFrame(data)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 224,
   "metadata": {},
   "outputs": [],
   "source": [
    "table1 = document.tables[1]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 202,
   "metadata": {},
   "outputs": [],
   "source": [
    "list_gt = ['基因型']\n",
    "for i in list_rs:\n",
    "    if i == '位点':\n",
    "        list_gt.append('基因型')\n",
    "    else:\n",
    "        list_gt.append(res.loc[res['检测位点'] == i, '检测结果'].iloc[0])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 233,
   "metadata": {},
   "outputs": [],
   "source": [
    "#for i in range(1, len(table1.rows)):\n",
    " #   table1.cell(i, 3).text = list_gt[i]\n",
    "from docx.shared import Pt\n",
    "from docx.enum.text import WD_PARAGRAPH_ALIGNMENT\n",
    "from docx.shared import RGBColor\n",
    "for i in range(0, len(table1.rows)):\n",
    "    if table1.cell(i, 3).text == '基因型':\n",
    "        pass\n",
    "    else:\n",
    "        table1.cell(i, 3).text = ''\n",
    "        table1.cell(i, 5).text = ''\n",
    "document.save('泛癌种50基因化疗部分模板0919.docx')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 235,
   "metadata": {},
   "outputs": [],
   "source": [
    "for i in range(0, len(table1.rows)):\n",
    "    if table1.cell(i, 3).text == '基因型':\n",
    "        pass\n",
    "    \n",
    "    \n",
    "    else:\n",
    "        #table1.cell(i, 3).text = list_gt[i]\n",
    "        run = table1.cell(i, 3).paragraphs[0].add_run(list_gt[i]) \n",
    "    #run.font.name = 'Arial'\n",
    "        run.font.size = Pt(10)\n",
    "        table1.cell(i,3).paragraphs[0].alignment = WD_PARAGRAPH_ALIGNMENT.CENTER\n",
    "        run = table1.cell(i, 5).paragraphs[0].add_run(list_gt[i])\n",
    "    "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 236,
   "metadata": {},
   "outputs": [],
   "source": [
    "document.save('泛癌种50基因化疗部分模板0919.docx')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 237,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<docx.table._Cell object at 0x11b242a58>\n",
      "<docx.table._Cell object at 0x120c39d30>\n",
      "<docx.table._Cell object at 0x120c39ba8>\n",
      "<docx.table._Cell object at 0x11e572128>\n",
      "<docx.table._Cell object at 0x11e572390>\n",
      "<docx.table._Cell object at 0x11f82a320>\n",
      "<docx.table._Cell object at 0x120e9a048>\n",
      "<docx.table._Cell object at 0x120e9afd0>\n",
      "<docx.table._Cell object at 0x120e9a518>\n",
      "<docx.table._Cell object at 0x120c53400>\n",
      "<docx.table._Cell object at 0x120c53668>\n",
      "<docx.table._Cell object at 0x120b4fb70>\n",
      "<docx.table._Cell object at 0x11b25cba8>\n",
      "<docx.table._Cell object at 0x11b25c9e8>\n",
      "<docx.table._Cell object at 0x1209604a8>\n",
      "<docx.table._Cell object at 0x11dbc5c50>\n",
      "<docx.table._Cell object at 0x120bbb6d8>\n",
      "<docx.table._Cell object at 0x11e344908>\n",
      "<docx.table._Cell object at 0x11b238a58>\n",
      "<docx.table._Cell object at 0x11b2427b8>\n",
      "<docx.table._Cell object at 0x11b242780>\n",
      "<docx.table._Cell object at 0x11c3389b0>\n",
      "<docx.table._Cell object at 0x11e572390>\n",
      "<docx.table._Cell object at 0x11e572198>\n",
      "<docx.table._Cell object at 0x11e5727b8>\n",
      "<docx.table._Cell object at 0x11b24ef60>\n",
      "<docx.table._Cell object at 0x11b24ee10>\n",
      "<docx.table._Cell object at 0x11b24e2e8>\n",
      "<docx.table._Cell object at 0x11b24eb38>\n",
      "<docx.table._Cell object at 0x120e9a7f0>\n",
      "<docx.table._Cell object at 0x120e9a6d8>\n",
      "<docx.table._Cell object at 0x120e9aac8>\n",
      "<docx.table._Cell object at 0x120e9acc0>\n",
      "<docx.table._Cell object at 0x120e9a588>\n",
      "<docx.table._Cell object at 0x120c53320>\n",
      "<docx.table._Cell object at 0x120b4fe80>\n",
      "<docx.table._Cell object at 0x120b4fd30>\n",
      "<docx.table._Cell object at 0x120b4fbe0>\n",
      "<docx.table._Cell object at 0x120b4f9b0>\n",
      "<docx.table._Cell object at 0x11b25cf98>\n",
      "<docx.table._Cell object at 0x120bbb400>\n",
      "<docx.table._Cell object at 0x120bf0908>\n",
      "<docx.table._Cell object at 0x11b2429b0>\n",
      "<docx.table._Cell object at 0x120c39dd8>\n",
      "<docx.table._Cell object at 0x120c396a0>\n",
      "<docx.table._Cell object at 0x120c39550>\n",
      "<docx.table._Cell object at 0x11e572780>\n",
      "<docx.table._Cell object at 0x11e572a90>\n",
      "<docx.table._Cell object at 0x11b24eb70>\n",
      "<docx.table._Cell object at 0x11b248be0>\n",
      "<docx.table._Cell object at 0x120e9abe0>\n",
      "<docx.table._Cell object at 0x120e9a710>\n",
      "<docx.table._Cell object at 0x120e9a080>\n",
      "<docx.table._Cell object at 0x120e9a518>\n",
      "<docx.table._Cell object at 0x120b4f940>\n",
      "<docx.table._Cell object at 0x120b4f128>\n",
      "<docx.table._Cell object at 0x120b4ffd0>\n",
      "<docx.table._Cell object at 0x11b25cb70>\n",
      "<docx.table._Cell object at 0x11b25c588>\n",
      "<docx.table._Cell object at 0x11b263f28>\n",
      "<docx.table._Cell object at 0x11b263278>\n",
      "<docx.table._Cell object at 0x11b263f28>\n",
      "<docx.table._Cell object at 0x11b263278>\n"
     ]
    }
   ],
   "source": [
    "for i in range(0, len(table1.rows)):\n",
    "    print(table1.cell(i,5))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 225,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['rs8175347',\n",
       " 'rs25487',\n",
       " 'rs1801133',\n",
       " 'rs11615',\n",
       " 'rs1695',\n",
       " 'rs67376798',\n",
       " 'rs1801019',\n",
       " 'rs1801133',\n",
       " 'rs1801019',\n",
       " 'rs8175347',\n",
       " 'rs1801133',\n",
       " 'rs11615',\n",
       " 'rs1801133',\n",
       " 'rs11615',\n",
       " 'rs1801133',\n",
       " 'rs11615',\n",
       " 'rs1801133',\n",
       " '位点',\n",
       " 'rs1042522',\n",
       " 'rs1695',\n",
       " 'rs1695',\n",
       " 'rs11615',\n",
       " 'rs1695',\n",
       " 'rs1695',\n",
       " 'rs1695',\n",
       " 'rs1142345',\n",
       " 'rs1042522',\n",
       " 'rs3212986',\n",
       " 'rs11615',\n",
       " 'rs3212986',\n",
       " 'rs8175347',\n",
       " 'rs1517114',\n",
       " 'rs3832043',\n",
       " 'rs4880',\n",
       " 'rs396991',\n",
       " 'rs1805087',\n",
       " 'rs1056892',\n",
       " 'rs3892097',\n",
       " 'rs1801133',\n",
       " 'rs67376798',\n",
       " 'rs3918290',\n",
       " 'rs1801131',\n",
       " '位点',\n",
       " 'rs67376798',\n",
       " 'rs3918290',\n",
       " 'rs67376798',\n",
       " 'rs3918290',\n",
       " 'rs1801131',\n",
       " 'rs11615',\n",
       " 'rs3212986',\n",
       " 'rs3212986',\n",
       " 'rs4880',\n",
       " 'rs11615',\n",
       " 'rs25487',\n",
       " 'rs1695',\n",
       " 'rs11615',\n",
       " 'rs25487',\n",
       " 'rs1695',\n",
       " 'rs2228001',\n",
       " 'rs25487',\n",
       " 'rs11615',\n",
       " 'rs1695']"
      ]
     },
     "execution_count": 225,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "list_rs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
